DelveInsight’s ‘Chronic Lower Back Pain (CLBP) Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the CLBP, historical and forecasted epidemiology as well as the CLBP market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
The CLBP market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM CLBP market size from 2019 to 2032. The Report also covers current CLBP treatment practice, market drivers, market barriers, SWOT analysis, reimbursement, and market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Some of the key facts of the Chronic Lower Back Pain Market Report:
- Among all the seven major markets, the United States accounts for the highest number of cases of CLBP.
- In 2021, the age-specific diagnosed prevalent cases of CLBP in the US were ~4,176,000; 5,076,000; 5,755,000; 6,056,000; 2,544,000; and 8,239,000 for the age groups, 18–29 years, 30–39 years, 40–49 years, 50–59 years, 60–69 years, and 70+ years respectively
Key benefits of the chronic lower back pain Market report:
- The report covers the descriptive overview of CLBP, explaining its causes, symptoms, pathophysiology, genetic basis, and currently available therapies.
- Comprehensive insight has been provided into CLBP epidemiology and treatment.
- Additionally, an all-inclusive account of both the current and emerging therapies for CLBP is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.
- A detailed review of the CLBP market; historical and forecasted is included in the report, covering the 7MM drug outreach.
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM CLBP market.
Got queries? Click here to know more about the Chronic Lower Back Pain Market Landscape
Chronic Lower Back Pain Overview
- Chronic low back pain (CLBP) is pain that persists for 12 weeks or longer, even after an initial injury or underlying cause of acute low back pain. Low back pain is very common, and at one point, everyone must have faced this problem.
- Lower back pain that is long-term (for more than 3 months) is called CLBP. This condition might originate from an injury, disease, or stress on different body structures. The pain may vary significantly and be felt as bone pain, nerve pain, or muscle pain, and its intensity ranges from mild to severe.
- The exact cause of this complex condition remains unclear. Due to its dynamic and fluctuating nature, its etiology and pathophysiology are more complex. While many patients with acute lower back pain improve clinically without specific treatment, it is less clear why others progress to develop recurrent or chronic symptoms
Chronic Lower Back Pain Epidemiological Insight:
- CLBP is a disorder that affects both males and females, majorly from the elderly age groups. It is one of the leading causes of disabilities around the globe. This condition puts an immense social and economic impact on the patient. CLBP has different associated risk factors that can contribute to the increased prevalence.
- The total prevalent cases of CLBP in the 7MM were ~76,851,000 in 2021. These cases of CLBP in the 7MM is expected to increase throughout the study period, i.e., 2019–2032.
- In the EU-5 countries, among the CLBP cases, Spain had the highest prevalent cases of CLBP with ~8,863,000, followed by the UK which had ~6,014,000 cases in 2021.
- Japan had ~12,717,000 cases of CLBP in 2021.
- Among the 7MM, in 2021, the lowest prevalent cases of CLBP was recorded in Italy.
Chronic Lower Back Pain Market Epidemiological Segmentation
- Chronic Lower Back Pain total prevalent population
- Chronic Lower Back Pain total diagnosed prevalent cases
- Chronic Lower Back Pain gender-specific diagnosed prevalent cases
- Chronic Lower Back Pain age-specific diagnosed prevalent cases
Chronic Lower Back Pain Market Outlook
CLBP is a complex process and comparable to how each patient has a very individualized disease process the treatment regimen is similarly individualized. There are several different medication classes, each with an exclusive mechanism of action that can help the practitioner in targeting a specific aspect of a patient’s pain. Moreover, patient‐specific factors are taken into account when developing a regimen to ensure adherence and improve outcomes.
Prior to initiating any pharmacologic treatment regimen for a patient, current consensus recommendations include discussing realistic expectations with the patient. This includes the expectation of a patient in terms of pain relief as well as functional goals that the patient should work toward. Additionally, clinicians encourage self‐care and education with evidence‐based materials.
Learn more by requesting for sample @chronic lower back pain Market Market Landscape
Chronic Lower Back Pain Market Key Companies
- Camurus/Braeburn Inc
- Scilex Holding
- Mesoblast Limited
- AnGes MG, Inc.
- And many others
Chronic Lower Back Pain Market Therapies
- Brixadi
- Semdexa
- Rexlemestrocel-L
- AMG0103
- And many others
Table of Contents
- Key Insights
- Report Introduction
- Executive Summary of chronic lower back pain Market
- Disease Background and Overview
- Epidemiology and patient population
- The United States
- EU 5
- chronic lower back pain Market Emerging Therapies
- chronic lower back pain Market Market Outlook
- Market Access and Reimbursement of Therapies
- Appendix
- chronic lower back pain Market Report Methodology
- DelveInsight Capabilities
- Disclaimer
- About DelveInsi
Click here to read more about chronic lower back pain Market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/